Skip to content
Menu

Caris Life Sciences, Inc. CAI

Full chart Compare
Set alert

Price alert · CAI

All alert types
18.54 USD -0.96 (-4.92%)

Regular-session close

18.54 0.00 0.00%

After hours · Nov 19, 4:26 PM ET

18.52 Day range 20.82
14.19 52-week range 36.50
YTD
-31.28%
1 year
-22.43%

5D -5.11 (-21.41%)

202224FriMonTueWedThu18.76
Market cap
5.32B
Revenue (ttm)
1.05B
Profit margin
9.16%
EPS (ttm)
1.66
Shares out
286.78M
P/E ratio
11.17
Forward P/E
68.41
YTD return
-31.28%
1-year return
-22.43%
Volume
3.60M
Avg volume
4.68M
Open
19.86
Previous close
19.50
Day's range
18.52 – 20.82
52-week range
14.19 – 36.50
Analysts
Buy
Price target
34.23 (+84.6%)
Earnings date
Feb 25, 2027

Key statistics

50-day average
29.12
200-day average
21.59
Enterprise value
5.29B
Price / sales
5.07
Price / book
8.31
Revenue growth
27.00%
Free cash flow
-25.86M
Total cash
767.38M
Total debt
463.02M
Return on equity
17.19%
Short % of float
9.64%

Fundamental scorecard

11 of 25 checks passed on CAI’s reported financials

ValueGrowthProfitabilityHealthDividend

11of 25 checks passed

  • Value 0 of 5
  • Growth 3 of 5
  • Profitability 3 of 5
  • Financial health 5 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
CAI Revenue — quarterly 275.36M
CAI Net income — quarterly 15.25M
CAI EPS — quarterly 0.05

Earnings

CAI recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 25, 2027Dec 30, 20260.06———
Nov 4, 2026Sep 30, 20260.028140.05+0.02+77.68%
Aug 5, 2026Jun 30, 20260.00587-0.0023-0.01-139.18%
May 7, 2026Mar 31, 2026-0.02-0.0018+0.02+91.00%
Feb 26, 2026Dec 31, 20250.010.28+0.27+2,700.00%
Nov 5, 2025Sep 30, 2025-0.080.08+0.16+200.00%

Upgrades / downgrades

CAI analyst upgrades and downgrades
DateFirmActionFromTo
Nov 10, 2026Piper SandlermainNeutralNeutral
Nov 6, 2026CitigroupmainBuyBuy
Nov 5, 2026TD CowenmainBuyBuy
Nov 5, 2026BTIGreitBuyBuy
Oct 27, 2026BTIGmainBuyBuy
Oct 19, 2026Canaccord GenuitymainHoldHold

About Caris Life Sciences, Inc.

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company's molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ whole transcriptome sequencing (WTS) tissue-based molecular profiling solutions; Caris Assure Platform WES/WTS blood-based molecular profiling solutions; Precision Whole Genome Platform, a whole genome sequencing (WGS) blood- and tissue-based profiling solutions; and Caris Detect, a WGS-based multi-cancer early detection solution; Caris WGS MRD a WGS and digital droplet polymerase reaction-based minimal residual disease solution; and Caris ChromoSeq, a WGS and WTS based assay for therapy selection in hematological cancers. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company provides its precision oncology solutions to customers, such as hospitals, institutions and patients. The company was founded in 2008 and is headquartered in Irving, Texas.

Sector
Healthcare
Industry
Biotechnology
Country
United States

News

Your note

Sign in to keep a note on CAI — it syncs with the Stock Master app.

Insider holders

CAI insider holders
InsiderRelationLatest transactionDateShares held
ADAPT I LTDBeneficial Owner of more than 10% of a Class of SecurityConversion of Exercise of derivative securityJun 19, 20250
BRILLE BRIAN J.Officer and DirectorConversion of Exercise of derivative securitySep 16, 2026730,303
CASTLEMAN PETER MDirectorStock Award(Grant)Aug 13, 202610,683,700
HALBERT DAVID DChief Executive OfficerStock Award(Grant)Mar 5, 2026123,640,000
HALBERT JON S.DirectorStock Award(Grant)Aug 13, 20261,490,410
JOHANSEN LAURA I.DirectorStock Award(Grant)Aug 13, 2026343,897

Institution ownership

CAI institution ownership
Holder% heldSharesValueReported
FMR, LLC13.37%38,330,630710.65MSep 29, 2026
AQR Capital Management, LLC2.86%8,210,498152.22MSep 29, 2026
Blackrock Inc.2.74%7,864,791145.81MSep 29, 2026
Shaw D.E. & Co., Inc.2.52%7,218,295133.83MSep 29, 2026
Vanguard Capital Management LLC2.00%5,733,874106.31MSep 29, 2026
Price (T.Rowe) Associates Inc1.68%4,814,27289.26MSep 29, 2026

Fund ownership

CAI fund ownership
Holder% heldSharesValueReported
Fidelity Contrafund1.52%4,366,37280.95MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.41%4,047,82075.05MJun 29, 2026
JPMorgan Trust II-JPMorgan Mid Cap Growth Fund1.16%3,320,98361.57MJun 29, 2026
SmallCap World Fund Inc1.05%3,007,13755.75MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund1.02%2,921,30754.16MJun 29, 2026
T. Rowe Price Mid-Cap Growth Fund, Inc.0.94%2,702,37950.10MJun 29, 2026